Trial Reporting in Immuno-Oncology (TRIO): An American Society of Clinical Oncology-Society for Immunotherapy of Cancer Statement

PURPOSE: To develop recommendations for clinical trial reporting that address the unique efficacy, toxicity, and combination and sequencing aspects of immuno-oncology (IO) treatments. METHODS: ASCO and the Society for Immunotherapy of Cancer (SITC) convened a working group that consisted of practici...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Clin Oncol
Autores principales: Tsimberidou, Apostolia M., Levit, Laura A., Schilsky, Richard L., Averbuch, Steven D., Chen, Daniel, Kirkwood, John M., McShane, Lisa M., Sharon, Elad, Mileham, Kathryn F., Postow, Michael A.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Clinical Oncology 2019
Materias:
ASCO Special Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6354771/
https://ncbi.nlm.nih.gov/pubmed/30339040
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.18.00145
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares